Skip to main content
. 2012 Nov 6;7(11):e48341. doi: 10.1371/journal.pone.0048341

Figure 1. Design of the reproducibility and validation study.

Figure 1

FFQ1 was administered during the first 24-HR and FFQ2 was administered during the last 24-HR. The four 24-HRs were administered at intervals of three months.